Sep 2026
Prospective Evaluation of Circulating Tumor DNA in Metastatic Hormone-Sensitive Prostate Cancer.
In this diverse cohort, a positive ctDNA TF at baseline was associated with worse outcomes in mHSPC and may potentially complement current further risk stratification tools.
C. Nguyen, I. Tsung, Jessica K. Lee et al.
· JCO Precision Oncology · 0 citations